The U.S. Food and Drug Administration (FDA) has approved paforacyanin (Cytalux) as an injectable contrast agent for adults with lung cancer. of new approvalGranted following priority...
New American Gastroenterological Association Clinical Practice Update for Evaluation and Management of Gastroesophageal reflux disease (GERD) focuses on providing personalized diagnostic and therapeutic strategies. This document...
Recent Comments